A Multiinstitutional Consensus Study on the Pathologic Diagnosis of Endometrial Hyperplasia and Carcinoma
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: The purpose of this study was to examine the reproducibility of both the diagnosis of endometrial hyperplasia (EH) or adenocarcinoma, and the histologic grading (HG) of endometrioid adenocarcinoma (EC). Methods: Ninety-three cases of EH or adenocarcinomas were reviewed independently by 21 pathologists of the Gynecologic Pathology Study Group. A consensus diagnosis was defined as agreement among more than two thirds of the 21 pathologists. Results: There was no agreement on the diagnosis in 13 cases (14.0%). According to the consensus review, six of the 11 EH cases (54.5%) were diagnosed as EH, 48 of the 57 EC cases (84.2%) were EC, and 5 of the 6 serous carcinomas (SC) (83.3%) were SC. There was no consensus for the 6 atypical EH (AEH) cases. On the HG of EC, there was no agreement in 2 cases (3.5%). According to the consensus review, 30 of the 33 G1 cases (90.9%) were G1, 11 of the 18 G2 cases (61.1%) were G2, and 4 of the 4 G3 cases (100.0%) were G3. Conclusions: The consensus study showed high agreement for both EC and SC, but there was no consensus for AEH. The reproducibility for the HG of G2 was poor. We suggest that simplification of the classification of EH and a two-tiered grading system for EC will be necessary.
Abstract
Background: The purpose of this study was to examine the reproducibility of both the diagnosis of endometrial hyperplasia (EH) or adenocarcinoma, and the histologic grading (HG) of endometrioid adenocarcinoma (EC). Methods: Ninety-three cases of EH or adenocarcinomas were reviewed independently by 21 pathologists of the Gynecologic Pathology Study Group. A consensus diagnosis was defined as agreement among more than two thirds of the 21 pathologists. Results: There was no agreement on the diagnosis in 13 cases (14.0%). According to the consensus review, six of the 11 EH cases (54.5%) were diagnosed as EH, 48 of the 57 EC cases (84.2%) were EC, and 5 of the 6 serous carcinomas (SC) (83.3%) were SC. There was no consensus for the 6 atypical EH (AEH) cases. On the HG of EC, there was no agreement in 2 cases (3.5%). According to the consensus review, 30 of the 33 G1 cases (90.9%) were G1, 11 of the 18 G2 cases (61.1%) were G2, and 4 of the 4 G3 cases (100.0%) were G3. Conclusions: The consensus study showed high agreement for both EC and SC, but there was no consensus for AEH. The reproducibility for the HG of G2 was poor. We suggest that simplification of the classification of EH and a two-tiered grading system for EC will be necessary.
참고문헌 (30)
- Silverberg SG, "Tumors of the uterine corpus and gestational trophoblastic disease. In: Silverberg S, Kurman RJ, editors. Atlas of tumor pathology, 3rd series, fascicle 3", pp.13~14 (1992), Armed Forces Institute of Pathology
- Mutter GL, "Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Goup", Gynecol Oncol, 76, pp.287~290 (2000)
- Kurman R, "The behavior of endometrial hyperplasia. A long-term study of ‘‘untreated’’ hyperplasia in 170 patients", Cancer, 56, pp.403~411 (1985)
- Hecht JL, "Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis", Mod Pathol, 18, pp.324~330 (2005)
- Mutter GL, "Endometrial intraepithelial neoplasia. In: Crum CP, Lee KR, eds. Diagnostic gynecologic and obstetric pathology", Elsevier Saunders, pp.493~518 (2006)
- Bergeron C, "A muticentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens", Am J Surg Pathol, 23, pp.1102~1108 (1999)
- Greven K, "Pathologic stage III endometrial carcinoma", Cancer, 71, pp.3697~3702 (1993)
- Lee KR, "Traditional and nontraditional histopathologic predictors of recurrence in uterine endometrioid adenocarcinoma", Gynecol Oncol, 54, pp.10~18 (1994)
- Zaino RJ, "The prognostic value of nuclear versus architectural grading in endometrial adenocarcinoma: a Gynecologic Oncology Group study", Int J Gynecol Pathol, 13, pp.29~36 (1994)
- Zaino RJ, "The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system. A Gynecologic Oncology Group study", Cancer, 75, pp.81~86 (1995)
- Silverberg SG, "Tumors of the uterine corpus: epithelial tumors and related lesions. In: Tavassoli FA, Devilee P, eds. WHO classification of tumors: pathology and genetics of tumors of the breast and female genital organs", pp.217~232 (2003), IARC Press
- Lax SF, "A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis", Am J Surg Pathol, 24, pp.1201~1208 (2000)
- Spiegel GW, "Endometrial carcinoma in situ in postmenopausal women", Am J Surg Pathol, 19, pp.417~432 (1995)
- Wheeler DT, "Minimal serous carcinoma", Am J Surg Pathol, 24, pp.797~806. (2000)
- Ambros RA, "Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation", Mod Pathol, 26, pp.1260~1267 (1995)
- Ioffe OB, "Recent developments and selected diagnostic problems in carcinomas of the endometrium", Am J Clin Pathol, 124, pp.42~51 (2005)
- Ferenzy A, "The biologic significance of cytologic atypia in progestogen treated endometrial hyperplasia", Am J Obstet Gynecol, 160, pp.126~131 (1989)
- Randall TC, "Progestin treatment of atypical hyperplasia and well differentiated adenocarcinoma of the endometrium in women under age 40", Obstet Gynecol, 90, pp.434~440 (1997)
- Zaino RJ, "Reproducibility of the diagnosis of atypical endometrial hyperplasia (AEH): a gynecologic oncology group study", Cancer, 106, pp.804~811 (2006)
- Kendall BS, "Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma", Am J Surg Pathol, 22, pp.1012~1019 (1998)
- Skov BG, "Comparison of the reproducibitiy of the WHO classifications of 1975 and 1994 of endometrial hyperplasia", Int J Gynecol Pathol, 16, pp.33~37 (1997)
- Silverberg SG, "The Endometrium. Pathologic principles and pitfalls", Arch Pathol Lab Med, 131, pp.372~382 (2007)
- Zaino RJ, "Endometrial hyperplasia and carcinoma. In: Hains and Taylor obstetrical and gynaecological pathology, 5th ed., edited by Fox H, Wells M, Churchill Livingstone", 443~495 (2003)
- Trimble CL, "Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia. A Gynecologic Oncology Group study", Cancer, 106, pp.812~819 (2006)
- Mutter GL, "Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia", Int J Gynecol Pathol, pp.103~114 (2007)
- Scholten AN, "Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma", Cancer, 100, pp.764~772 (2004)
- Darvishian F, "Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases", Am J Surg Pathol, 28, pp.1568~1578 (2004)
- Trahan S, "Serous papillary carcinoma of the endometrium arising from endometrial polyps: a clinical, histological, and immunohistochemical study of 13 cases", Hum Pathol, 36, pp.1316~1321 (2005)
- Lax SF, "Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification", Virchows Arch, 444, pp.213~223 (2004)
- Silva EG, "Serous carcinoma in endometrial polyps", Mod Pathol, 3, pp.120~128 (1990)